• Emerging devices like Colovac and Leakguard show promise, with FDA breakthrough designations.
• These innovations aim to minimize need for diverting stomas, which carry their own risks.

Further validation through large-scale trials is needed to confirm their efficacy.

• Improved technology could enhance postoperative outcomes and patient quality of life.